PDGFRB and B-cell chronic lymphocytic leukemia: To illustrate, interaction of MSC with CLL cells increases the production platelet-derived growth factor (PDGF), which binds to its receptor, PDGFR, leading to secretion of VEGF and making an angiogenic switch, associated with drug protection and disease progression [77].